Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population()

Detalles Bibliográficos
Autores principales: Camacho, Jorge, Zulaica, Joao, Giménez, Estela, Rusu, Luciana, Velandia-Álvarez, Sebastian, Albert, Eliseo, Peiró, Salvador, Vanaclocha, Hermelinda, Limón, Ramón, Geller, Ron, Navarro, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805797/
https://www.ncbi.nlm.nih.gov/pubmed/36599404
http://dx.doi.org/10.1016/j.jinf.2022.12.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805797/
https://www.ncbi.nlm.nih.gov/pubmed/36599404
http://dx.doi.org/10.1016/j.jinf.2022.12.029

Ejemplares similares